Report: Colts WR Alec Pierce undergoes another PRP treatment as he continues rehabbing left ankle

The Indianapolis Colts’ wide receiver room faces an additional uncertainty as Alec Pierce reportedly received another PRP injection while rehabbing a left ankle issue, according to James Boyd of The Athletic and relayed by Yahoo Sports on August 10, 2026. The report frames the procedure as part of ongoing pain and tissue management rather than a confirmed setback, but it does raise questions about how steadily Pierce can progress ahead of the season.

Pierce’s ankle rehab already included minor cleanup surgery earlier in the offseason, which is part of why the follow-on treatment stands out. PRP, or platelet-rich plasma, is commonly used in sports medicine to support recovery from certain types of soft-tissue irritation, inflammation, or lingering pain. In practical terms for an NFL receiver, it can affect timing and comfort during the sharp, high-volume movements of training camp and preseason.

According to the report, the injection was tied to the same left ankle being worked through during his rehab. That continuity suggests medical staff are still prioritizing recovery of the area rather than moving on to a new phase that would typically involve returning to full-speed workload without further intervention. Even when procedures are intended to help, repeat treatments often report that the underlying symptoms have been persistent enough to warrant additional medical attention.

For the Colts, Pierce’s availability matters because the team must build chemistry and timing with multiple wide receivers as camps transition to preseason game reps and then, ultimately, regular-season planning. Wideouts are asked to run precise routes, decelerate hard, and change direction repeatedly, so ankle comfort is rarely a minor detail. Any delay or fluctuation can ripple into practice availability, snap distribution, and how the offense manages the installation of route concepts.

There is also a broader roster-building implication. Indianapolis has to ensure it can cover reps at every stage of camp if a receiver is limited. Even without a designation that the injury is deteriorating, the existence of another injection makes it reasonable to expect that his workload could be monitored closely, especially during periods when practices become more physically demanding.

The situation remains a report, not an official transaction or team statement in the public record provided here. Until the Colts and Pierce’s camp staff provide additional context, observers should treat details about pain management and rehab steps as information about process, not a medical prognosis. What to watch next is straightforward: whether Pierce returns to full participation, how quickly he can handle high-tempo practices, and whether the Colts need to shift reps among their starting and depth options at the position.